3. As of noon trading, Vertex Pharmaceuticals ( VRTX) is down $2.54 (-3.0%) to $83.06 on heavy volume Thus far, 3.7 million shares of Vertex Pharmaceuticals exchanged hands as compared to its average daily volume of 1.7 million shares. The stock has ranged in price between $82.34-$87.47 after having opened the day at $84.40 as compared to the previous trading day's close of $85.60. Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. Vertex Pharmaceuticals has a market cap of $11.5 billion and is part of the health care sector. Shares are up 26.2% year to date as of the close of trading on Friday. TheStreet Ratings rates Vertex Pharmaceuticals as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full Vertex Pharmaceuticals Ratings Report now. Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.